X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (214) 214
Newspaper Article (54) 54
Publication (40) 40
Book Chapter (11) 11
Patent (7) 7
Book / eBook (3) 3
Book Review (3) 3
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (96) 96
index medicus (87) 87
female (60) 60
male (54) 54
rheumatology (54) 54
adult (43) 43
middle aged (43) 43
systemic lupus erythematosus (37) 37
aged (34) 34
lupus (33) 33
abridged index medicus (31) 31
treatment outcome (31) 31
lupus erythematosus, systemic - drug therapy (23) 23
animals (18) 18
article (18) 18
stroke (18) 18
double-blind method (17) 17
arthritis (16) 16
clinical neurology (16) 16
disease-activity (16) 16
immunology (15) 15
severity of illness index (15) 15
autoimmune diseases (14) 14
patients (14) 14
research (14) 14
clinical trials (13) 13
monoclonal-antibody (13) 13
risk factors (13) 13
aged, 80 and over (12) 12
antibodies, monoclonal - therapeutic use (12) 12
belimumab (12) 12
classification (12) 12
therapy (12) 12
1506 (11) 11
b-lymphocyte stimulator (11) 11
biochemistry (11) 11
rheumatoid-arthritis (11) 11
care and treatment (10) 10
dose-response relationship, drug (10) 10
lupus erythematosus, systemic - immunology (10) 10
lupus nephritis - drug therapy (10) 10
mice (10) 10
rheumatoid arthritis (10) 10
safety (10) 10
adolescent (9) 9
antibodies, monoclonal, humanized - therapeutic use (9) 9
disease (9) 9
immunosuppressive agents - therapeutic use (9) 9
inflammation (9) 9
lupus nephritis (9) 9
nephritis (9) 9
operas (9) 9
risk (9) 9
rituximab (9) 9
usage (9) 9
antibodies, antinuclear - blood (8) 8
b-lymphocytes - immunology (8) 8
chronic conditions (8) 8
corticosteroids (8) 8
diagnosis (8) 8
double-blind (8) 8
enzymes (8) 8
interferon (8) 8
ischemia (8) 8
lupus erythematosus, systemic - complications (8) 8
medicine, research & experimental (8) 8
mortality (8) 8
prognosis (8) 8
retrospective studies (8) 8
studies (8) 8
surgery (8) 8
testing (8) 8
young adult (8) 8
analysis (7) 7
antibodies, monoclonal, humanized (7) 7
association (7) 7
beer (7) 7
binding sites (7) 7
cardiac & cardiovascular systems (7) 7
chemistry (7) 7
compositions thereof (7) 7
culture media (7) 7
enzymology (7) 7
erythematosus (7) 7
gene expression (7) 7
human necessities (7) 7
hygiene (7) 7
investigating or analysing materials by determining theirchemical or physical properties (7) 7
lupus erythematosus, systemic - blood (7) 7
measuring (7) 7
medical or veterinary science (7) 7
metallurgy (7) 7
microbiology (7) 7
microorganisms or enzymes (7) 7
mutation or genetic engineering (7) 7
mycophenolate-mofetil (7) 7
organic chemistry (7) 7
peptides (7) 7
physics (7) 7
preparations for medical, dental, or toilet purposes (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JCR: Journal of Clinical Rheumatology, ISSN 1076-1608, 08/2017, Volume 23, Issue 5, pp. 278 - 284
Journal Article
The Lancet, ISSN 0140-6736, 02/2019, Volume 393, Issue 10170, pp. 402 - 403
[...]we are carrying out a more extensive benefit–risk assessment in the ongoing baricitinib phase 3 global systemic lupus erythematosus programme... 
Lupus | Creatine kinase | Neutrophils | Health risks | Lipids | Arthritis | Creatine | Thrombosis | Chronic conditions | Systemic lupus erythematosus | Rheumatoid arthritis | Risk assessment | Janus kinase
Journal Article
Journal Article
Circulation Research, ISSN 0009-7330, 02/2017, Volume 120, Issue 3, pp. 527 - 540
Background:Cryptogenic stroke accounts for 30% to 40% of ischemic stroke. It is essential to determine the possible culprit because this will improve secondary... 
Literature reviews | Prevention | Stroke | Fibrillation | Ischemia | Arteriosclerosis | Aortic arch | Atherosclerosis | Clinical trials | Aorta
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 02/2016, Volume 75, Issue 2, pp. 332 - 40
ObjectivesTo evaluate the efficacy and safety of tabalumab, a human IgG4 monoclonal antibody that neutralises membrane and soluble B-cell activating factor... 
Complement C3 | Humans | Middle Aged | Complement C4 | B-Lymphocytes | Male | Journal Article | Dose-Response Relationship, Drug | Young Adult | Clinical Trial, Phase III | Injections, Subcutaneous | Lupus Erythematosus, Systemic | Adult | Female | Severity of Illness Index | Autoantibodies | Double-Blind Method | Drug Administration Schedule | Antibodies, Antinuclear | Treatment Outcome | Antibodies, Monoclonal | Randomized Controlled Trial | B-Cell Activating Factor | Adolescent | Biomarkers | Multicenter Study | Aged | African Continental Ancestry Group | TRIALS | BELIMUMAB | FLARES | PREDICTORS | LYMPHOCYTE STIMULATOR | CLASSIFICATION | LIGAND | RHEUMATOLOGY | DISEASE-ACTIVITY | Autoantibodies - blood | B-Cell Activating Factor - antagonists & inhibitors | Lupus Erythematosus, Systemic - ethnology | Antibodies, Antinuclear - blood | Lupus Erythematosus, Systemic - drug therapy | B-Lymphocytes - metabolism | B-Cell Activating Factor - administration & dosage | Complement C4 - metabolism | Complement C3 - metabolism | Biomarkers - blood | Antibodies, Monoclonal - administration & dosage | Care and treatment | Usage | Systemic lupus erythematosus | Estrogen | Monoclonal antibodies | Clinical trials | Dosage and administration | Research | Lupus | Immunology | Laboratories | Suicides & suicide attempts | Response rates | Tumor necrosis factor-TNF | Mental depression | Drug dosages
Journal Article
The Lancet, ISSN 0140-6736, 06/2019, Volume 393, Issue 10188, pp. 2344 - 2358
Journal Article
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 06/2018, Volume 70, Issue 6, pp. 868 - 877
Objective We undertook this US multicenter continuation study (GlaxoSmithKline study BEL112233; ClinicalTrials.gov identifier: NCT00724867) to assess long‐term... 
Lupus | Damage assessment | Effectiveness | Identification methods | Estrogens | Prednisone | Patients | Chronic conditions | Systemic lupus erythematosus | Lymphocytes B | CD20 antigen | Safety | Autoimmune diseases
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 02/2014, Volume 41, Issue 2, pp. 300 - 309
Journal Article